Alvotech

Alvotech is a leading biotechnology research company committed to improving patient lives and fostering a sustainable global healthcare ecosystem. Through the development and broadening accessibility of biosimilars, Alvotech strives to make a significant impact on healthcare worldwide. The company's dedication to innovation and excellence drives its mission to deliver high-quality biopharmaceuticals to a global market.

Operating from its primary address at Saemundargata 15-19, Reykjavik, 101, IS, Alvotech also maintains a strong presence with additional locations at Thurgauerstrasse 54, Zürich, 8050, CH; Karl-Heinz-Beckurts-Str. 13, Jülich, 52428, DE; 1201 Wilson Blvd, 2130, Arlington, Virginia 22209, US; and Feodor-Lynen Straße 35, Hannover, Hannover 30625, DE. This expansive network enables Alvotech to effectively conduct research and development, ensuring regulatory compliance and fostering robust business development.

With a focus on research and development, Alvotech is dedicated to advancing biopharmaceutical solutions and cell line development. The company's work in biotechnology and biogenerics positions it as a key player in the pharmaceutical and health sectors. Alvotech continues to expand its capabilities and is poised for future growth and success. We invite the Alvotech management team to create a customized and exclusive company showcase and product listing on our platform.